Keystone Biologicals Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, has been acquired by BioIVT, a provider of research models and services for drug and diagnostic development. This acquisition is expected to expand BioIVT's disease-state portfolio both by volume and product range.
"With the addition of Keystone Biologicals, BioIVT broadens its product offerings and better supports clients in the in vitro diagnostic (IVD) market," said BioIVT CEO Jeffrey Gatz. "This acquisition furthers our mission of becoming the partner of choice for both biopharmaceutical and diagnostic clients."
Financial details about this transaction were not disclosed.